名称 | EML4(E13)-ALK(E20) Translocation |
型号 | CBP20209D |
报价 | |
特点 | EML4(E13)-ALK(E20) Translocation |
产品搜索
相关文章
联系我们
联系人:蒋经理
电话:4008750250
号码:
手机:18066071954
地址:南京市栖霞区纬地路9号
Email: zhangxiangwen@cobioer.com
电话:4008750250
号码:
手机:18066071954
地址:南京市栖霞区纬地路9号
Email: zhangxiangwen@cobioer.com
产品展示 / PRODUCTS
基因检测标准品 > Translocation > CBP20209DEML4(E13)-ALK(E20) Translocation
- 详细内容
EML4(E13)-ALK(E20) Translocation EML4(E13)-ALK(E20) Translocation
Introduction | |
Format | DNA |
Description | EML4-ALK results from the fusion of EML4 and ALK, resulting in constitutive kinase activity, transformation in cultured cells, and tumor formation in mouse models . EML4-ALK fusions have been associated with non-small cell lung cancer . |
Technical Data | |
Left Gene | EML4(E13) |
Left Breakpoint | chr2:425****6:+ |
Right Gene | ALK(E20) |
Right Breakpoint | chr2:294****4:- |
%AF | 50% |
Buffer | Tris-EDTA |
Product Information | |
Intended Use | Research Use Only |
Unit Size | 1ug |
Concentration | Download for COA |
Purity | Download for COA |
RNA electrophoresis | Download for COA |
Sanger sequencing | Download for COA |
Storage | 4℃ |
Expiry | 36 months from the date of manufacture |
" _ue_custom_node_="true">